Beam’s medicine uses a technology known as base editing to activate a gene in stem cells collected from people with sickle ...
BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...
Beam Therapeutics has presented the first clinical data on its base editing technology. | Beam Therapeutics has presented the ...
The first two Sickle Cell Disease patients admitted to the Sickle Cell Foundation of Nigeria/Lagos University Teaching ...
Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the ...
With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...
It’s a rare condition triggered by exercise that is too intense in someone with the sickle cell trait, a sickle cell gene inherited from just one parent. Such exercise can cause the body’s red blood ...
He noted that to prevent stroke in children with sickle cell anaemia, measures such as screening, chronic blood transfusion ...
Beam Therapeutics gave an initial look at the first handful of patients who received its experimental gene-edited treatment ...
The Sickle Cell Foundation of Nigeria (SCFN) on Tuesday announced its first successful bone marrow transplant (BMT). Its ...
According to Uganda's Ministry of Health, around 250,000 people in the country live with sickle cell disease, including an estimated 20,000 to 25,000 babies ...
Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This ...